The novel second-generation triterpenoid SCY-247 maintains in vitro and in vivo activity against resistant Candida glabrata.

Antimicrob Agents Chemother · 2026 · PMC13041391 · PMID 41711446

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Improvements in survival were also observed, although differences with the untreated control group did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The novel second-generation triterpenoid SCY-247 maintains &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; activity against resistant &lt;i&gt;Candida glabrata&lt;/i&gt;.

The sentences

The novel second-generation triterpenoid SCY-247 maintains <i>in vitro</i> and <i>in vivo</i> activity against resistant <i>Candida glabrata</i>.